المؤلفون: Vaduganathan, Muthiah, Claggett, Brian L., Kulac, Ian J., Miao, Zi Michael, Desai, Akshay S., Jhund, Pardeep S., Henderson, Alasdair D., Brinker, Meike, Lay-Flurrie, James, Viswanathan, Prabhakar, Scheerer, Markus Florian, Lage, Andrea, Lam, Carolyn S.P., Senni, Michele, Shah, Sanjiv J., Voors, Adriaan A., Zannad, Faiez, Pitt, Bertram, McMurray, John J.V., Solomon, Scott D.

المساهمون: Bayer

المصدر: Circulation ; volume 151, issue 2, page 149-158 ; ISSN 0009-7322 1524-4539

الاتاحة: https://doi.org/10.1161/circulationaha.124.072055
https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.124.072055

المؤلفون: Pabon, Maria A., Vaduganathan, Muthiah, Claggett, Brian L., Chatur, Safia, Siqueira, Sara, Marti‐Castellote, Pablo, de Boer, Rudolf A., Hernandez, Adrian F., Inzucchi, Silvio E., Kosiborod, Mikhail N., Lam, Carolyn S.P., Martinez, Felipe, Shah, Sanjiv J., Desai, Akshay S., Jhund, Pardeep S., McMurray, John J.V., Solomon, Scott D., Vardeny, Orly

المساهمون: AstraZeneca

المصدر: European Journal of Heart Failure ; volume 26, issue 12, page 2532-2540 ; ISSN 1388-9842 1879-0844

الاتاحة: https://doi.org/10.1002/ejhf.3410
https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.3410

المؤلفون: Monzo, Luca, Bresso, Emmanuel, Dickstein, Kenneth, Pitt, Bertram, Cleland, John G.F., Anker, Stefan, D, Lam, Carolyn S.P., Mehra, Mandeep, R, van Veldhuisen, Dirk, J, Greenberg, Barry, Zannad, Faiez, Girerd, Nicolas

المساهمون: Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists Vandoeuvre-les-Nancy (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu Nancy, French-Clinical Research Infrastructure Network - F-CRIN Paris (Cardiovascular & Renal Clinical Trialists - CRCT), University of Bergen (UiB), Stavanger University Hospital, University of Michigan Ann Arbor, University of Michigan System, University of Glascow, German Center for Cardiovascular Research (DZHK), Berlin Institute of Health (BIH), Berlin Institute of Health Center for Regenerative Therapies (BCRT), National Heart Centre Singapore (NHCS), Duke-NUS Medical School Singapore, University Medical Center Groningen Groningen (UMCG), University of Groningen Groningen, Brigham & Women’s Hospital Boston (BWH), Harvard Medical School Boston (HMS), Department of Medicine Univ California San Diego (MED - UC San Diego), School of Medicine Univ California San Diego (UC San Diego), University of California San Diego (UC San Diego), University of California (UC)-University of California (UC)-University of California San Diego (UC San Diego), University of California (UC)-University of California (UC), Dr. Girerd was supported by the Contrat de Plan Etat Région Lorraine and the Fonds Européen de Développement Régional(FEDER) IT2MP., European Project

المصدر: ISSN: 1388-9842 ; European Journal of Heart Failure ; https://hal.univ-lorraine.fr/hal-04843102 ; European Journal of Heart Failure, 2024, ⟨10.1002/ejhf.3547⟩.

مصطلحات موضوعية: AF, atrial fibrillation ARB, angiotensin receptor blocker BMI, body mass index CCB, calcium channel blocker CV, cardiovascular CVD, cardiovascular death CVH, cardiovascular hospitalization DBP, diastolic blood pressure eGFR, estimated glomerular filtration rate HFH, heart failure hospitalization LVEF, left ventricular ejection fraction MACE, major adverse cardiovascular events MI, myocardial infarction PAD, peripheral artery disease PP, pulse pressure SBP, systolic blood pressure WBC, white blood cell Machine learning Clustering HFrEF Clinical outcomes Ischaemic heart disease, atrial fibrillation, ARB, angiotensin receptor blocker, BMI, body mass index, CCB, calcium channel blocker, CV, cardiovascular, CVD, cardiovascular death, CVH

الاتاحة: https://hal.univ-lorraine.fr/hal-04843102
https://hal.univ-lorraine.fr/hal-04843102v1/document
https://hal.univ-lorraine.fr/hal-04843102v1/file/European%20J%20of%20Heart%20Fail%20-%202024%20-%20Monzo%20-%20Machine%20learning%20approach%20to%20identify%20phenotypes%20in%20patients%20with%20ischaemic%20heart.pdf
https://doi.org/10.1002/ejhf.3547

المؤلفون: Patel, Kershaw V., Segar, Matthew W., Klonoff, David C., Khan, Muhammad Shahzeb, Usman, Muhammad Shariq, Lam, Carolyn S.P., Verma, Subodh, Defilippis, Andrew P., Nasir, Khurram, Bakker, Stephan J.L., Westenbrink, B. Daan, Dullaart, Robin P.F., Butler, Javed, Vaduganathan, Muthiah, Pandey, Ambarish

المصدر: Patel , K V , Segar , M W , Klonoff , D C , Khan , M S , Usman , M S , Lam , C S P , Verma , S , Defilippis , A P , Nasir , K , Bakker , S J L , Westenbrink , B D , Dullaart , R P F , Butler , J , Vaduganathan , M & Pandey , A 2024 , ' Optimal Screening for Predicting and Preventing the Risk of Heart Failure among Adults with Diabetes Without Atherosclerotic Cardiovascular Disease : A Pooled Cohort Analysis ....

مصطلحات موضوعية: biomarkers, heart failure, risk, type 2 diabetes mellitus

وصف الملف: application/pdf

الاتاحة: https://hdl.handle.net/11370/69edfc94-1194-4742-b78c-2080b12bec5c
https://research.rug.nl/en/publications/69edfc94-1194-4742-b78c-2080b12bec5c
https://doi.org/10.1161/CIRCULATIONAHA.123.067530
https://pure.rug.nl/ws/files/1159073916/patel-et-al-2023-optimal-screening-for-predicting-and-preventing-the-risk-of-heart-failure-among-adults-with-diabetes.pdf
http://www.scopus.com/inward/record.url?scp=85179801161&partnerID=8YFLogxK

المؤلفون: Mc Causland, Finnian R., Vaduganathan, Muthiah, Claggett, Brian L., Kulac, Ian J., Desai, Akshay S., Jhund, Pardeep S., Henderson, Alasdair D., Brinker, Meike, Perkins, Robert, Scheerer, Markus F., Schloemer, Patrick, Lam, Carolyn S.P., Senni, Michele, Shah, Sanjiv J., Voors, Adriaan A., Zannad, Faiez, Pitt, Bertram, McMurray, John J.V., Solomon, Scott D.

المساهمون: Bayer AG

المصدر: Journal of the American College of Cardiology ; ISSN 0735-1097

الاتاحة: https://doi.org/10.1016/j.jacc.2024.10.091
https://api.elsevier.com/content/article/PII:S0735109724102525?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0735109724102525?httpAccept=text/plain

المؤلفون: Pabon, Maria A, Vaduganathan, Muthiah, Claggett, Brian L., Chatur, Safia, Siqueira, Sara, Marti‐Castellote, Pablo, de Boer, Rudolf A., Hernandez, Adrian F., Inzucchi, Silvio E., Kosiborod, Mikhail N., Lam, Carolyn S.P., Martinez, Felipe, Shah, Sanjiv J., Desai, Akshay S., Jhund, Pardeep S., McMurray, John J.V., Solomon, Scott D., Vardeny, Orly

وصف الملف: text

Relation: https://eprints.gla.ac.uk/336363/1/336363.pdf; Pabon, M. A. et al. (2024) In‐hospital course of patients with heart failure with improved ejection fraction in the DELIVER trial. European Journal of Heart Failure , (doi:10.1002/ejhf.3410 ) (PMID:39300780) (Early Online Publication)

الاتاحة: https://eprints.gla.ac.uk/336363/
https://eprints.gla.ac.uk/336363/1/336363.pdf

المؤلفون: Arrigo, Mattia, Davison, Beth, Edwards, Christopher, Adamo, Marianna, Ambrosy, Andrew P., Barros, Marianela, Biegus, Jan, Celutkiene, Jelena, Čerlinskaitė-Bajorė, Kamilė, Chioncel, Ovidiu, Cohen-Solal, Alain, Damasceno, Albertino, Diaz, Rafael, Filippatos, Gerasimos, Gayat, Etienne, Kimmoun, Antoine, Lam, Carolyn S.P., Metra, Marco, Novosadova, Maria, Pagnesi, Matteo, Pang, Peter S., Ponikowski, Piotr, Saidu, Hadiza, Sliwa, Karen, Takagi, Koji, Ter Maaten, Jozine M., Tomasoni, Daniela, Voors, Adriaan A., Cotter, Gad, Mebazaa, Alexandre

المصدر: Arrigo , M , Davison , B , Edwards , C , Adamo , M , Ambrosy , A P , Barros , M , Biegus , J , Celutkiene , J , Čerlinskaitė-Bajorė , K , Chioncel , O , Cohen-Solal , A , Damasceno , A , Diaz , R , Filippatos , G , Gayat , E , Kimmoun , A , Lam , C S P , Metra , M , Novosadova , M , Pagnesi , M , Pang , P S , Ponikowski , P , Saidu , H , Sliwa , K ....

وصف الملف: application/pdf

الاتاحة: https://hdl.handle.net/11370/8992b941-dc19-4cb2-8b8a-0d2c0fdc6a50
https://research.rug.nl/en/publications/8992b941-dc19-4cb2-8b8a-0d2c0fdc6a50
https://doi.org/10.1016/j.ahj.2024.04.019
https://pure.rug.nl/ws/files/1109572557/Characteristics_treatment_and_outcomes_of_early_vs._late_enrollees_of_the_STRONG-HF_trial.pdf
http://www.scopus.com/inward/record.url?scp=85194561668&partnerID=8YFLogxK

المؤلفون: Kittipibul, Veraprapas, Mentz, Robert J., Young, Rebecca, Butler, Javed, Ezekowitz, Justin A., Lam, Carolyn S.P., Ponikowski, Piotr, Voors, Adriaan, Corda, Stefano, McMullan, Ciaran, O'Connor, Christopher M., Anstrom, Kevin J., Armstrong, Paul W.

المساهمون: Merck Sharp and Dohme United Kingdom, Bayer

المصدر: ESC Heart Failure ; ISSN 2055-5822 2055-5822

الاتاحة: http://dx.doi.org/10.1002/ehf2.15134
https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.15134

المؤلفون: Cao, Thong Huy, Tay, Wan Ting, Jones, Donald J.L., Cleland, John G.F., Tromp, Jasper, Emmens, Johanna Elisabeth, Teng, Tiew‐hwa Katherine, Chandramouli, Chanchal, Slingsby, Oliver Charles, Anker, Stefan, D, Dickstein, Kenneth, Filippatos, Gerasimos, Lang, Chim, C, Metra, Marco, Ponikowski, Piotr, Samani, Nilesh, J, van Veldhuisen, Dirk, J, Zannad, Faiez, Anand, Inder, S, Lam, Carolyn S.P., Voors, Adriaan, A, Ng, Leong

المساهمون: University of Leicester, University Hospitals of Leicester NHS Trust, National Heart Centre Singapore (NHCS), Duke-National University of Singapore, University of Glascow, Duke-NUS Medical School Singapore, National University of Singapore and the National University Health System, University of Groningen Groningen, Duke-National University of Singapore Graduate Medical School, German Center for Cardiovascular Research (DZHK), Berlin Institute of Health (BIH), Berlin Institute of Health Center for Regenerative Therapies (BCRT), Charité - UniversitätsMedizin = Berlin University Medicine, University of Bergen (UiB), Stavanger University Hospital, National and Kapodistrian University of Athens (NKUA), Université d'Athènes (UOA), “Attikon” University Hospital, University of Dundee, Ninewells Hospital and Medical School Dundee, Università degli Studi di Brescia = University of Brescia (UniBs), University of Wrocław Poland (UWr), University Medical Center Groningen Groningen (UMCG), Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists Vandoeuvre-les-Nancy (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu Nancy, French-Clinical Research Infrastructure Network - F-CRIN Paris (Cardiovascular & Renal Clinical Trialists - CRCT), University of Minnesota Medical School, University of Minnesota System (UMN), European Project: 242209,EC:FP7:HEALTH,FP7-HEALTH-2009-single-stage,BIOSTAT-CHF(2010), European Project

المصدر: ISSN: 1388-9842 ; European Journal of Heart Failure ; https://hal.univ-lorraine.fr/hal-04680212 ; European Journal of Heart Failure, 2024, ⟨10.1002/ejhf.3378⟩.

مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

Relation: info:eu-repo/grantAgreement/EC/FP7/242209/EU/A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure/BIOSTAT-CHF

الاتاحة: https://hal.univ-lorraine.fr/hal-04680212
https://hal.univ-lorraine.fr/hal-04680212v1/document
https://hal.univ-lorraine.fr/hal-04680212v1/file/European%20J%20of%20Heart%20Fail%20-%202024%20-%20Cao%20-%20Heart%20failure%20with%20improved%20versus%20persistently%20reduced%20left%20ventricular%20ejection.pdf
https://doi.org/10.1002/ejhf.3378

المؤلفون: Segar, Matthew W., Usman, Muhammad Shariq, Patel, Kershaw V., Khan, Muhammad Shahzeb, Butler, Javed, Manjunath, Lakshman, Lam, Carolyn S.P., Verma, Subodh, Willett, DuWayne, Kao, David, Januzzi, James L., Pandey, Ambarish

المصدر: European Journal of Heart Failure ; volume 26, issue 10, page 2183-2192 ; ISSN 1388-9842 1879-0844

الاتاحة: http://dx.doi.org/10.1002/ejhf.3443
https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.3443

المؤلفون: Lassen, Mats Christian Højbjerg, Ostrominski, John W., Inzucchi, Silvio E., Claggett, Brian L., Kulac, Ian, Jhund, Pardeep, de Boer, Rudolf A., Hernandez, Adrian F., Kosiborod, Mikhail N., Lam, Carolyn S.P., Martinez, Felipe A., Shah, Sanjiv J., Desai, Akshay S., Petersson, Magnus, Langkilde, Anna Maria, Docherty, Kieran F., McMurray, John J.V., Solomon, Scott D., Vaduganathan, Muthiah

وصف الملف: text

Relation: https://eprints.gla.ac.uk/331370/1/331370.pdf; Lassen, M. C. H. et al. (2024) Effect of dapagliflozin in patients with diabetes and heart failure with mildly reduced or preserved ejection fraction according to background glucose‐lowering therapy: a pre‐specified analysis of the DELIVER trial. European Journal of Heart Failure , 26(7), pp. 1539-1548. (doi:10.1002/ejhf.3269 ) (PMID:38745498)

الاتاحة: https://eprints.gla.ac.uk/331370/
https://eprints.gla.ac.uk/331370/1/331370.pdf

المؤلفون: Vaduganathan, Muthiah, Claggett, Brian L., Lam, Carolyn S.P., Pitt, Bertram, Senni, Michele, Shah, Sanjiv J., Voors, Adriaan A., Zannad, Faiez, Desai, Akshay S., Jhund, Pardeep S., Viswanathan, Prabhakar, Bomfim Wirtz, Antonieta, Schloemer, Patrick, Lay‐Flurrie, James, McMurray, John J.V., Solomon, Scott D.

وصف الملف: text

Relation: https://eprints.gla.ac.uk/329391/1/329391.pdf; Vaduganathan, M. et al. (2024) Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: Rationale and design of the FINEARTS‐HF trial. European Journal of Heart Failure , 26(6), pp. 1324-1333. (doi:10.1002/ejhf.3253 ) (PMID:38742248)

الاتاحة: https://eprints.gla.ac.uk/329391/
https://eprints.gla.ac.uk/329391/1/329391.pdf

المؤلفون: Yang, Mingming, Henderson, Alasdair, D, Talebi, Atefeh, Atherton, John, J, Chiang, Chern-En, Chopra, Vijay, Comin-Colet, Josep, Kosiborod, Mikhail, N, Kerr Saraiva, Jose, F, Claggett, Brian, L, Desai, Akshay, S, Kolkhof, Peter, Viswanathan, Prabhakar, Lage, Andrea, Lam, Carolyn S.P., Senni, Michele, Shah, Sanjiv, J, Rohwedder, Katja, Voors, Adriaan, A, Zannad, Faiez, Pitt, Bertram, Vaduganathan, Muthiah, Jhund, Pardeep, S, Solomon, Scott, D, McMurray, John J.V.

المساهمون: British Heart Foundation Glasgow Cardiovascular Research Centre (BHF GCRC), University of Glasgow-NHS Greater Glasgow & Clyde Glasgow (NHSGGC), University of Glasgow, Royal Brisbane and Women's Hospital, The University of Queensland (UQ All campuses : Brisbane, Dutton Park Gatton, Herston, St Lucia and other locations ), Taipei Veterans General Hospital and National Yang Ming Chiao Tung University, MAX Superspecialty Hospital Saket, New Delhi, India (MSH), Institut d'Investigació Biomèdica de Bellvitge = Bellvitge Biomedical Research Institute (IDIBELL), Universitat de Barcelona (UB), L'Hospitalet de Llobregat, Saint Luke's Mid America Heart Institute, University of Missouri Kansas City (UMKC), University of Missouri System, Instituto de Pesquisa Clínica de Campinas, Brigham and Women's Hospital Boston, Harvard Medical School Boston (HMS), Bayer, Research and Development, Cardiology and Nephrology Clinical Development, Bayer SA, National Heart Centre Singapore (NHCS), Duke-NUS Medical School Singapore, Hospital Papa Giovanni XXIII (Hosp P Giovanni XXIII), Università degli Studi di Milano-Bicocca = University of Milano-Bicocca (UNIMIB), Feinberg School of Medicine Northwestern University, Evanston ( Northwestern University Medical School ), Northwestern University Evanston, Bayer AG, Global Medical Affairs, University Medical Center Groningen Groningen (UMCG), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists Vandoeuvre-les-Nancy (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu Nancy, French-Clinical Research Infrastructure Network - F-CRIN Paris (Cardiovascular & Renal Clinical Trialists - CRCT), University of Michigan Ann Arbor, University of Michigan System, The FINEARTS-HF trial was funded by Bayer

المصدر: ISSN: 0735-1097.

مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

الاتاحة: https://hal.univ-lorraine.fr/hal-04791472
https://hal.univ-lorraine.fr/hal-04791472v1/document
https://hal.univ-lorraine.fr/hal-04791472v1/file/1-s2.0-S0735109724085322-main.pdf
https://doi.org/10.1016/j.jacc.2024.09.023

المؤلفون: Reddy, Yogesh N.V., Butler, Javed, Anstrom, Kevin, J, Blaustein, Robert, O, Bonaca, Marc, P, Corda, Stefano, Ezekowitz, Justin, A, Lam, Carolyn S.P., Lewis, Eldrin, F, Lindenfeld, Joann, Mcmullan, Ciaran, J, Mentz, Robert, J, O'Connor, Christopher, Patel, Mahesh, Ponikowski, Piotr, Rosano, Giuseppe M.C., Saldarriaga, Clara, I, Senni, Michele, Udelson, James, Voors, Adriaan, A, Zannad, Faiez

المساهمون: Mayo Clinic, Baylor Scott and White Research Institute Dallas, TX, USA, University of Southern Mississippi (USM), University of North Carolina System (UNC), Merck & Co., Inc, University of Colorado Colorado Springs, Bayer AG Germany, University of Alberta, Canadian VIGOUR Centre, National Heart Centre Singapore (NHCS), Duke-NUS Medical School Singapore, Stanford School of Medicine Stanford, Stanford Medicine, Stanford University-Stanford University, Vanderbilt Heart and Vascular Institute, Nashville, Tennessee, Duke University Medical Center, Inova Heart and Vascular Institute Falls Church, VA, USA (IHVI), Wrocław Medical University, St George’s University Hospitals, Cardio VID Clinic, Hospital Papa Giovanni XXIII (Hosp P Giovanni XXIII), Università degli Studi di Milano-Bicocca = University of Milano-Bicocca (UNIMIB), Tufts Medical Center Boston, University Medical Center Groningen Groningen (UMCG), Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists Vandoeuvre-les-Nancy (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu Nancy, French-Clinical Research Infrastructure Network - F-CRIN Paris (Cardiovascular & Renal Clinical Trialists - CRCT), The VICTOR trial is supported by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Rahway, NJ, USA and Bayer AG, Wuppertal, Germany.

المصدر: ISSN: 1388-9842 ; European Journal of Heart Failure ; https://hal.univ-lorraine.fr/hal-04791115 ; European Journal of Heart Failure, 2024, ⟨10.1002/ejhf.3501⟩.

مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

الاتاحة: https://hal.univ-lorraine.fr/hal-04791115
https://hal.univ-lorraine.fr/hal-04791115v1/document
https://hal.univ-lorraine.fr/hal-04791115v1/file/European%20J%20of%20Heart%20Fail%20-%202024%20-%20Reddy%20-%20Vericiguat%20Global%20Study%20in%20Participants%20with%20Chronic%20Heart%20Failure%20Design%20of%20the-1.pdf
https://doi.org/10.1002/ejhf.3501

المؤلفون: Vaduganathan, Muthiah, Filippatos, Gerasimos, Claggett, Brian, L, Desai, Akshay, Jhund, Pardeep, S, Henderson, Alasdair, Brinker, Meike, Kolkhof, Peter, Schloemer, Patrick, Lay-Flurrie, James, Viswanathan, Prabhakar, Lam, Carolyn S.P., Senni, Michele, Shah, Sanjiv J, Voors, Adriaan, A, Zannad, Faiez, Rossing, Peter, Ruilope, Luis, Anker, Stefan, D, Pitt, Bertram, Agarwal, Rajiv, Mcmurray, John, Solomon, Scott, D

المساهمون: Brigham and Women's Hospital Boston, Harvard Medical School Boston (HMS), National and Kapodistrian University of Athens (NKUA), “Attikon” University Hospital, University of Glasgow, Bayer, Research & Development, Pharmaceuticals, Università degli Studi di Milano-Bicocca = University of Milano-Bicocca (UNIMIB), Hospital Papa Giovanni XXIII (Hosp P Giovanni XXIII), Feinberg School of Medicine Northwestern University, Evanston ( Northwestern University Medical School ), Northwestern University Evanston, Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists Vandoeuvre-les-Nancy (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu Nancy, French-Clinical Research Infrastructure Network - F-CRIN Paris (Cardiovascular & Renal Clinical Trialists - CRCT), IT University of Copenhagen (ITU), Steno Diabetes Center, Hospital Universitario 12 de Octubre Madrid, University of Groningen Groningen, University of Michigan Ann Arbor, University of Michigan System, Indiana University School of Medicine, Indiana University System

المصدر: ISSN: 1078-8956.

مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

Relation: info:eu-repo/semantics/altIdentifier/pmid/39468366; PUBMED: 39468366

الاتاحة: https://hal.univ-lorraine.fr/hal-04791034
https://hal.univ-lorraine.fr/hal-04791034v1/document
https://hal.univ-lorraine.fr/hal-04791034v1/file/s41591-024-03372-1.pdf
https://doi.org/10.1038/s41591-024-03372-1

المؤلفون: Desai, Akshay, S, Vaduganathan, Muthiah, Claggett, Brian, L, Kulac, Ian, J, Jhund, Pardeep, S, Cunningham, Jonathan, Borentain, Maria, Lay-Flurrie, James, Viswanathan, Prabhakar, Rohwedder, Katja, Amarante, Flaviana, Lam, Carolyn S.P., Senni, Michele, Shah, Sanjiv, J, Voors, Adriaan, A, Zannad, Faiez, Pitt, Bertram, Kosiborod, Mikhail, McMurray, John J.V., Solomon, Scott, D

المساهمون: Harvard Medical School Boston (HMS), Brigham and Women's Hospital Boston, University of Glasgow, Bayer, Research & Development, Pharmaceuticals, Bayer plc, Research & Development, Bayer AG Germany, National Heart Centre Singapore (NHCS), Duke-NUS Medical School Singapore, Hospital Papa Giovanni XXIII (Hosp P Giovanni XXIII), Università degli Studi di Milano-Bicocca = University of Milano-Bicocca (UNIMIB), Feinberg School of Medicine Northwestern University, Evanston ( Northwestern University Medical School ), Northwestern University Evanston, University Medical Center Groningen Groningen (UMCG), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists Vandoeuvre-les-Nancy (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu Nancy, French-Clinical Research Infrastructure Network - F-CRIN Paris (Cardiovascular & Renal Clinical Trialists - CRCT), University of Michigan Ann Arbor, University of Michigan System, Saint Luke's Mid America Heart Institute, The FINEARTS-HF trial was funded by Bayer AG

المصدر: ISSN: 0735-1097.

مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

الاتاحة: https://hal.univ-lorraine.fr/hal-04790188
https://hal.univ-lorraine.fr/hal-04790188v1/document
https://hal.univ-lorraine.fr/hal-04790188v1/file/1-s2.0-S0735109724084523-main.pdf
https://doi.org/10.1016/j.jacc.2024.09.004

المؤلفون: Vaduganathan, Muthiah, Claggett, Brian, L, Desai, Akshay, S, Jhund, Pardeep, S, Lam, Carolyn S.P., Senni, Michele, Shah, Sanjiv, J, Voors, Adriaan, A, Zannad, Faiez, Pitt, Bertram, Mcmurray, John Jv., Solomon, Scott, D

المساهمون: Harvard Medical School Boston (HMS), Brigham and Women's Hospital Boston, University of Glasgow, National Heart Centre Singapore (NHCS), Duke-NUS Medical School Singapore, Hospital Papa Giovanni XXIII (Hosp P Giovanni XXIII), Università degli Studi di Milano-Bicocca = University of Milano-Bicocca (UNIMIB), Feinberg School of Medicine Northwestern University, Evanston ( Northwestern University Medical School ), Northwestern University Evanston, University Medical Center Groningen Groningen (UMCG), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists Vandoeuvre-les-Nancy (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu Nancy, French-Clinical Research Infrastructure Network - F-CRIN Paris (Cardiovascular & Renal Clinical Trialists - CRCT), University of Michigan Ann Arbor, University of Michigan System, FINEARTS-HF was funded by Bayer AG

المصدر: ISSN: 0735-1097.

مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

الاتاحة: https://hal.univ-lorraine.fr/hal-04790093
https://hal.univ-lorraine.fr/hal-04790093v1/document
https://hal.univ-lorraine.fr/hal-04790093v1/file/1-s2.0-S0735109724085127-main.pdf
https://doi.org/10.1016/j.jacc.2024.09.018

المؤلفون: Chimura, Misato, Petrie, Mark, C, Schou, Morten, Martinez, Felipe, A, Henderson, Alasdair, D, Claggett, Brian, L, Desai, Akshay, S, Kolkhof, Peter, Viswanathan, Prabhakar, Lage, Andrea, Lam, Carolyn S.P., Senni, Michele, Shah, Sanjiv, J, Rohwedder, Katja, Mueller, Katharina, Voors, Adriaan, A, Zannad, Faiez, Pitt, Bertram, Vaduganathan, Muthiah, Jhund, Pardeep, S, Solomon, Scott, D, McMurray, John J.V.

المساهمون: British Heart Foundation Glasgow Cardiovascular Research Centre (BHF GCRC), University of Glasgow-NHS Greater Glasgow & Clyde Glasgow (NHSGGC), University of Glasgow, Herlev and Gentofte Hospital, Universidad Nacional de Córdoba Argentina, Brigham and Women's Hospital Boston, Harvard Medical School Boston (HMS), Bayer AG Germany, National Heart Centre Singapore (NHCS), Duke-NUS Medical School Singapore, Hospital Papa Giovanni XXIII (Hosp P Giovanni XXIII), Università degli Studi di Milano-Bicocca = University of Milano-Bicocca (UNIMIB), Feinberg School of Medicine Northwestern University, Evanston ( Northwestern University Medical School ), Northwestern University Evanston, University Medical Center Groningen Groningen (UMCG), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), University of Michigan Ann Arbor, University of Michigan System, University of Glascow, The FINEARTS-HF trial was funded by Bayer.

المصدر: ISSN: 1941-3289.

مصطلحات موضوعية: age, finerenone, heart failure, hospitalization, [SDV]Life Sciences [q-bio]

Relation: info:eu-repo/semantics/altIdentifier/pmid/39342655; PUBMED: 39342655; PUBMEDCENTRAL: PMC11573060

الاتاحة: https://hal.univ-lorraine.fr/hal-04786089
https://hal.univ-lorraine.fr/hal-04786089v1/document
https://hal.univ-lorraine.fr/hal-04786089v1/file/chimura-et-al-2024-finerenone-improves-outcomes-in-patients-with-heart-failure-with-mildly-reduced-or-preserved.pdf
https://doi.org/10.1161/CIRCHEARTFAILURE.124.012437

المؤلفون: Docherty, Kieran, F, Henderson, Alasdair, D, Jhund, Pardeep, S, Claggett, Brian, L, Desai, Akshay, S, Mueller, Katharina, Viswanathan, Prabhakar, Scalise, Andrea, Lam, Carolyn S.P., Senni, Michele, Shah, Sanjiv, J, Voors, Adriaan, A, Zannad, Faiez, Pitt, Bertram, Vaduganathan, Muthiah, Solomon, Scott, D, Mcmurray, John Jv.

المساهمون: University of Glasgow, British Heart Foundation Glasgow Cardiovascular Research Centre (BHF GCRC), University of Glasgow-NHS Greater Glasgow & Clyde Glasgow (NHSGGC), Harvard Medical School Boston (HMS), Brigham & Women’s Hospital Boston (BWH), Bayer AG Germany, Bayer plc, Research & Development, Bayer Hispania S.L, National Heart Centre Singapore (NHCS), Duke-NUS Medical School Singapore, Università degli Studi di Milano-Bicocca = University of Milano-Bicocca (UNIMIB), Hospital Papa Giovanni XXIII (Hosp P Giovanni XXIII), Feinberg School of Medicine Northwestern University, Evanston ( Northwestern University Medical School ), Northwestern University Evanston, University of Groningen Groningen, Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists Vandoeuvre-les-Nancy (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu Nancy, French-Clinical Research Infrastructure Network - F-CRIN Paris (Cardiovascular & Renal Clinical Trialists - CRCT), The FINEARTS-HF trial was funded by Bayer

المصدر: ISSN: 0009-7322.

مصطلحات موضوعية: ClinicalTrials.go, NCT04435626 and EudraCT 2020-000306-29 Heart failure ejection fraction aldosterone finerenone, NCT04435626 and EudraCT 2020-000306-29 Heart failure, ejection fraction, aldosterone, finerenone, [SDV]Life Sciences [q-bio]

الاتاحة: https://hal.univ-lorraine.fr/hal-04770113
https://hal.univ-lorraine.fr/hal-04770113v1/document
https://hal.univ-lorraine.fr/hal-04770113v1/file/docherty-et-al-2024-efficacy-and-safety-of-finerenone-across-the-ejection-fraction-spectrum-in-heart-failure-with.pdf
https://doi.org/10.1161/CIRCULATIONAHA.124.072011

المؤلفون: Vaduganathan, Muthiah, Claggett, Brian, L, Kulac, Ian, J, Miao, Zi Michael, Desai, Akshay, S, Jhund, Pardeep, S, Henderson, Alasdair, D, Brinker, Meike, Lay-Flurrie, James, Viswanathan, Prabhakar, Scheerer, Markus Florian, Lage, Andrea, Lam, Carolyn S.P., Senni, Michele, Shah, Sanjiv, J, Voors, Adriaan, A, Zannad, Faiez, Pitt, Bertram, McMurray, John J.V., Solomon, Scott, D

المساهمون: Brigham & Women’s Hospital Boston (BWH), Harvard Medical School Boston (HMS), University of Glasgow, Bayer plc, Research & Development, National Heart Centre Singapore (NHCS), Duke-NUS Medical School Singapore, Hospital Papa Giovanni XXIII (Hosp P Giovanni XXIII), Università degli Studi di Milano-Bicocca = University of Milano-Bicocca (UNIMIB), Feinberg School of Medicine Northwestern University, Evanston ( Northwestern University Medical School ), Northwestern University Evanston, University of Groningen Groningen, Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists Vandoeuvre-les-Nancy (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu Nancy, French-Clinical Research Infrastructure Network - F-CRIN Paris (Cardiovascular & Renal Clinical Trialists - CRCT), University of Michigan Ann Arbor, University of Michigan System, FINEARTS-HF was funded by Bayer AG

المصدر: ISSN: 0009-7322.

مصطلحات موضوعية: heart failure with preserved ejection fraction mineralocorticoid receptor antagonist SGLT2 inhibitor, heart failure with preserved ejection fraction, mineralocorticoid receptor antagonist, SGLT2 inhibitor, [SDV]Life Sciences [q-bio]

الاتاحة: https://hal.univ-lorraine.fr/hal-04769871
https://hal.univ-lorraine.fr/hal-04769871v1/document
https://hal.univ-lorraine.fr/hal-04769871v1/file/vaduganathan-et-al-2024-effects-of-the-non-steroidal-mra-finerenone-with-and-without-concomitant-sglt2-inhibitor-use-in.pdf
https://doi.org/10.1161/CIRCULATIONAHA.124.072055